Literature DB >> 32283235

Reply to: "Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection".

Beuy Joob1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32283235      PMCID: PMC7151475          DOI: 10.1016/j.jaad.2020.04.035

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
To the Editor: We appreciate the additional information from Jimenez-Cauhe et al on our report on a skin rash in a patient with COVID-19. Jimenez-Cauhe et al showed a clinical picture of a skin rash at the axilla of a patient. As a new emerging virus infection, the dermatologic presentation is an interesting clinical feature. The skin rash in our previous publication that looked like the skin rash in dengue copresented with thrombocytopenia in a patient with COVID-19. Nevertheless, there is also the possibility that there might be other forms of COVID-19 skin rashes. In a previous report on a classical coronavirus infection, the rash appeared to be recurrent; “target-like purpuric plaques” was reported as another clinical presentation. In the present clinical case by Jimenez-Cauhe et al, the rash might be a coincidence or an actual COVID-19–induced skin rash. Whether the lesion described by Jimenez- Cauhe et al is related to the pathophysiologic process of COVID-19 or not should be further studied.
  3 in total

1.  Acute Hemorrhagic Edema of Infancy after Coronavirus Infection with Recurrent Rash.

Authors:  Hannah Chesser; Jeffrey M Chambliss; Eric Zwemer
Journal:  Case Rep Pediatr       Date:  2017-01-24

2.  Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection.

Authors:  Juan Jimenez-Cauhe; Daniel Ortega-Quijano; Marta Prieto-Barrios; Oscar M Moreno-Arrones; Diego Fernandez-Nieto
Journal:  J Am Acad Dermatol       Date:  2020-04-10       Impact factor: 11.527

3.  COVID-19 can present with a rash and be mistaken for dengue.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  3 in total
  7 in total

Review 1.  Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.

Authors:  F González González; C Cortés Correa; E Peñaranda Contreras
Journal:  Actas Dermosifiliogr       Date:  2021-01-28

2.  Could injured skin be a reservoir for SARS-CoV-2 virus spread?

Authors:  Lamia Hamouda Elgarhy; Mohamed Labib Salem
Journal:  Clin Dermatol       Date:  2020-06-09       Impact factor: 3.541

Review 3.  Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations.

Authors:  Vikram Thakur; Radha Kanta Ratho; Pradeep Kumar; Shashi Kant Bhatia; Ishani Bora; Gursimran Kaur Mohi; Shailendra K Saxena; Manju Devi; Dhananjay Yadav; Sanjeet Mehariya
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

Review 4.  COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.

Authors:  Jacek Baj; Hanna Karakuła-Juchnowicz; Grzegorz Teresiński; Grzegorz Buszewicz; Marzanna Ciesielka; Ryszard Sitarz; Alicja Forma; Kaja Karakuła; Wojciech Flieger; Piero Portincasa; Ryszard Maciejewski
Journal:  J Clin Med       Date:  2020-06-05       Impact factor: 4.241

5.  A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?

Authors:  N Skroza; N Bernardini; V Balduzzi; A Mambrin; A Marchesiello; S Michelini; E Tolino; I Proietti; C Di Cristofano; V Petrozza; C Potenza
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-15       Impact factor: 9.228

6.  Comment on "Chilblains-like lesions in children following suspected COVID-19 infection".

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  Pediatr Dermatol       Date:  2020-05       Impact factor: 1.997

7.  Systemic lupus erythematosus, varicella-like rash, and COVID-19.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  J Med Virol       Date:  2020-09-30       Impact factor: 20.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.